Skip to main content

Peer Review reports

From: Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma

Original Submission
12 Apr 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
15 Aug 2012 Reviewed Reviewer Report - Salah-Eddin Al-Batran
31 Aug 2012 Reviewed Reviewer Report - Peter Reichardt
29 Oct 2012 Author responded Author comments - Martina Mayr
Resubmission - Version 3
29 Oct 2012 Submitted Manuscript version 3
Publishing
19 Nov 2012 Editorially accepted
10 Dec 2012 Article published 10.1186/1471-2407-12-587

You can find further information about peer review here.

Back to article page